CHD8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.941620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.787200E-01
Normal-vs-Stage2
1.763560E-01
Normal-vs-Stage3
6.406000E-02
Normal-vs-Stage4
9.329200E-01
Stage1-vs-Stage2
7.235400E-01
Stage1-vs-Stage3
3.252100E-02
Stage1-vs-Stage4
5.291200E-01
Stage2-vs-Stage3
4.532300E-02
Stage2-vs-Stage4
5.103200E-01
Stage3-vs-Stage4
1.280640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.841240E-01
Normal-vs-AfricanAmerican
6.332800E-01
Normal-vs-Asian
1.263570E-01
Caucasian-vs-AfricanAmerican
4.677600E-01
Caucasian-vs-Asian
2.974800E-01
AfricanAmerican-vs-Asian
2.749000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.607630E-01
Normal-vs-Female
2.573400E-01
Male-vs-Female
5.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.424800E-01
Normal-vs-Age(41-60Yrs)
3.677400E-01
Normal-vs-Age(61-80Yrs)
1.509810E-01
Normal-vs-Age(81-100Yrs)
1.245350E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.502400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.378200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.235400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.939300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.332400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.799700E-02
Normal-vs-Daily Drinker
6.902300E-02
Normal-vs-Weekly Drinker
2.171800E-01
Normal-vs-Occasional Drinker
4.681800E-01
Normal-vs-Social Drinker
4.464800E-01
Non Drinker-vs-Daily Drinker
9.613800E-01
Non Drinker-vs-Weekly Drinker
6.113000E-01
Non Drinker-vs-Occasional Drinker
4.166100E-02
Non Drinker-vs-Social Drinker
7.518100E-02
Daily Drinker-vs-Weekly Drinker
6.412600E-01
Daily Drinker-vs-Occasional Drinker
4.936400E-02
Daily Drinker-vs-Social Drinker
8.390400E-02
Weekly Drinker-vs-Occasional Drinker
2.391800E-01
Weekly Drinker-vs-Social Drinker
3.159400E-01
Occasional Drinker-vs-Social Drinker
8.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.898650E-01
Normal-vs-Grade 2
7.865600E-02
Normal-vs-Grade 3
4.006400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.575600E-01
Grade 1-vs-Grade 3
3.435400E-01
Grade 1-vs-Grade 4
1.898650E-01
Grade 2-vs-Grade 3
5.821800E-02
Grade 2-vs-Grade 4
7.865600E-02
Grade 3-vs-Grade 4
4.006400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.563810E-01
Normal-vs-NonDiabetic
1.324050E-01
Diabetic-vs-NonDiabetic
7.562800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.203800E-02
Normal-vs-NoPancreatitis
1.662570E-01
Pancreatitis-vs-NoPancreatitis
1.764210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.581000E-01
Normal-vs-N1
1.787810E-01
N0-vs-N1
9.670000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.473400E-01
Normal-vs-TP53-NonMutant
4.582400E-01
TP53-Mutant-vs-TP53-NonMutant
8.796800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
